ArticleMolecular therapy. Nucleic acids2022

A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells.

Seung Bum Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.